NASDAQ STOCKHOLM HAS APPROVED APPLICATION FOR DE-LISTING

Allenex AB (publ) announced on 20 May 2016 that the company had decided to apply
for de-listing of the Allenex share from Nasdaq Stockholm. The application has
now been approved.

The last day of trading in the Allenex share will be Wednesday 8 June 2016.

For more information please contact:
Anders Karlsson, CEO Allenex AB, and ph.: +4670-918 00 10, e-mail:
anders.karlsson@allenex.se

Allenex AB discloses the information provided herein pursuant to the Securities
Markets Act and /or the Financial Instruments Trading Act. The information was
submitted for publication on May 25, 2016, at 08.00 CET.  Allenex is a life
science-company that develops, manufacture, market and sell products for safer
transplants of organs and bone marrow on the global market. Allenex is listed on
NASDAQ OMX Stockholm Small Cap (ticker: ALNX). 57 persons are employed in the
Allenex group.